NDC11 00078018001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00078-0180-01 | 00078-0180 |
| 00078-0180-1 | 00078-0180 |
| 00078-180-01 | 00078-180 |
| 0078-0180-01 | 0078-0180 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sandostatin | OCTREOTIDE ACETATE | Novartis Pharmaceuticals Corporation | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 2026-07-22 | Warnings, Adverse reactions | 0078-0180-01 0078-0180 00078018001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.